Legal & General Group’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.3M Sell
59,050
-4,311
-7% -$1.15M ﹤0.01% 931
2025
Q4
$15.6M Sell
63,361
-2,454
-4% -$517K ﹤0.01% 950
2025
Q3
$11.6M Sell
65,815
-2,578
-4% -$386K ﹤0.01% 1124
2025
Q2
$9.4M Buy
68,393
+1,884
+3% +$277K ﹤0.01% 1224
2025
Q1
$12M Sell
66,509
-2,916
-4% -$490K ﹤0.01% 1046
2024
Q4
$10.9M Buy
69,425
+3,170
+5% +$562K ﹤0.01% 1121
2024
Q3
$12.1M Buy
66,255
+1,666
+3% +$321K ﹤0.01% 1072
2024
Q2
$11.9M Buy
64,589
+45,039
+230% +$7.56M ﹤0.01% 1040
2024
Q1
$3.48M Buy
19,550
+458
+2% +$63.6K ﹤0.01% 1689
2023
Q4
$2.37M Sell
19,092
-435
-2% -$48.2K ﹤0.01% 1867
2023
Q3
$2.27M Buy
19,527
+821
+4% +$100K ﹤0.01% 1846
2023
Q2
$2.2M Buy
18,706
+9,457
+102% +$966K ﹤0.01% 1886
2023
Q1
$740K Buy
9,249
+2,129
+30% +$167K ﹤0.01% 2223
2022
Q4
$564K Buy
7,120
+155
+2% +$11.5K ﹤0.01% 2305
2022
Q3
$485K Buy
6,965
+387
+6% +$28K ﹤0.01% 2357
2022
Q2
$431K Buy
6,578
+45
+0.7% +$2.8K ﹤0.01% 2380
2022
Q1
$435K Buy
6,533
+370
+6% +$23.1K ﹤0.01% 2432
2021
Q4
$432K Buy
6,163
+568
+10% +$33.1K ﹤0.01% 2457
2021
Q3
$293K Buy
5,595
+2,816
+101% +$167K ﹤0.01% 2573
2021
Q2
$189K Buy
2,779
+109
+4% +$7.61K ﹤0.01% 2547
2021
Q1
$206K Buy
2,670
+281
+12% +$20.4K ﹤0.01% 2450
2020
Q4
$144K Hold
2,389
﹤0.01% 2487
2020
Q3
$102K Sell
2,389
-355
-13% -$15.4K ﹤0.01% 2483
2020
Q2
$113K Buy
2,744
+273
+11% +$13.1K ﹤0.01% 2494
2020
Q1
$107K Sell
2,471
-469
-16% -$24.5K ﹤0.01% 2391
2019
Q4
$163K Buy
2,940
+414
+16% +$20.3K ﹤0.01% 2448
2019
Q3
$88K Buy
2,526
+1,066
+73% +$47.7K ﹤0.01% 2562
2019
Q2
$59K Buy
+1,460
New +$47.7K ﹤0.01% 2705

Other funds holding KRYS